000			02043 a2200613 4500
005			20250517163211.0
264		0	_c20190111
008			201901s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2017.31 _2doi
040			_aNLM _beng _cNLM
100	1		_aLoft, N D
245	0	0	_aAssociations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis. _h[electronic resource]
260			_bThe pharmacogenomics journal _c05 2018
300			_a494-500 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdalimumab _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aDenmark
650	0	4	_aEtanercept _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfliximab _xadministration & dosage
650	0	4	_aInterleukin-1beta _xgenetics
650	0	4	_aLymphocyte Antigen 96 _xgenetics
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aPharmacogenetics _xmethods
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aReceptors, Interleukin-1 _xgenetics
650	0	4	_aToll-Like Receptor 2 _xgenetics
650	0	4	_aToll-Like Receptor 9 _xgenetics
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aUstekinumab _xadministration & dosage
700	1		_aSkov, L
700	1		_aIversen, L
700	1		_aGniadecki, R
700	1		_aDam, T N
700	1		_aBrandslund, I
700	1		_aHoffmann, H J
700	1		_aAndersen, M R
700	1		_aDessau, R B
700	1		_aBergmann, A C
700	1		_aAndersen, N M
700	1		_aAndersen, P S
700	1		_aBank, S
700	1		_aVogel, U
700	1		_aAndersen, V
773	0		_tThe pharmacogenomics journal _gvol. 18 _gno. 3 _gp. 494-500
856	4	0	_uhttps://doi.org/10.1038/tpj.2017.31 _zAvailable from publisher's website
999			_c27356827 _d27356827